Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc.(TRDA) | 4,381,062 | 4,381,062 | 0 | $39.60M | $29.44M | 67.92% | -$10.16M |
| Dyne Therapeutics, Inc.(DYN) | 682,376 | 682,376 | 0 | $7.14M | $6.50M | 14.99% | -$641.4K |
| Werewolf Therapeutics, Inc.(HOWL) | 4,309,860 | 4,309,860 | 0 | $4.19M | $4.70M | 10.84% | +$508.6K |
| Repare Therapeutics, Inc. | 1,121,318 | 1,121,318 | 0 | $1.11M | $1.56M | 3.60% | +$453.0K |
| Adaptimmune Therapeutics plcADS(ADAPY) | 5,335,715 | 4,809,677 | -526,038 | $1.05M | $1.15M | 2.66% | +$101.7K |
| iTeos Therapeutics, Inc. | 2,738,785 | 0 | -2,738,785 | $16.35M | $0 | — | -$16.35M |